Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Internet

Stock in News: Google (NASDAQ GOOG) Claims Samsung Already has iPhone 6 Like Products

As the “Internet of Things,” a societal revolution that will connect smart household appliances with cars, cell phones and a master home operating system, becomes more reality than fantasy, a fight to rule this world could emerge between two major players: Google Inc (NASDAQ GOOG) and Apple Inc (NASDAQ AAPL). In a recent interview on Bloomberg TV with Stephanie Ruhle and Erik Schatzker, Google Chairman … Continue reading Stock in News: Google (NASDAQ GOOG) Claims Samsung Already has iPhone 6 Like Products

Richard Atkins
Biotech Finance News
BioTech, Finance

Biotech Stock Gilead Down Due To Weak Data Results

Shares of Gilead Sciences (GILD) declined approximately 0.9% to close the trading session on Sep 17 at $103.84 following a couple of setbacks — the failure of an oncology candidate to meet the primary endpoint in a phase II study and highly concerning data on the company’s blockbuster hepatitis C drug Sovaldi. Gilead’s pipeline candidate simtuzumab in combination with Eli Lilly and Company’s (LLY) Gemzar … Continue reading Biotech Stock Gilead Down Due To Weak Data Results

Richard Atkins
Biotech Stock
BioTech, Finance

Active Stock in News: Bayer/Regeneron Successfully Expand Eylea Label

The HealthCare segment at Bayer (BAYRY) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan. The drug was approved by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of myopic choroidal neovascularization (myopic CNV). Eylea’s approval in the myopic CNV indication was based on encouraging results from the phase III MYRROR study. The drug … Continue reading Active Stock in News: Bayer/Regeneron Successfully Expand Eylea Label

Richard Atkins
Finance, Software

Bitcoin News: Swedish Research Says Bitcoin Not Affecting Economy

Bitcoin has not affected the stability of Sweden’s economy, according to a new paper published by the country’s central bank. The latest issue of the Sveriges Riksbank Economic Review, published on 18th September, includes the article What is Bitcoin by Bjorn Segendorf, from the bank’s Financial Stability Department. Segendorf provides an overview of the bitcoin protocol, mining and price movements. He also includes a section … Continue reading Bitcoin News: Swedish Research Says Bitcoin Not Affecting Economy

Richard Atkins
Finance, Internet

Stock Focus: Microsoft (NASDAQ MSFT) confirms Windows 9 Event on Sept 30

Microsoft is headed to the backyard of Apple and other tech giants with a San Francisco event to close the month. Since 1995, Microsoft Corporation (NASDAQ MSFT) has unveiled eight new versions of its Windows operating system. Oddly, they have followed a pattern of roughly “good,” “awful,” “good” and so forth. As most would agree that 2012’s Windows 8 was rubbish there are high hopes … Continue reading Stock Focus: Microsoft (NASDAQ MSFT) confirms Windows 9 Event on Sept 30

Richard Atkins
Finance, Mobile

Stock in News: Apple (NASDAQ AAPL) & the Bash Bug

Millions learned today that they might be running machines with a “bug” more dangerous than “Heartbleed”. Bash comes pre-installed on both Apple Inc (NASDAQ AAPL)’s iMac and MacBook computers. It allows hackers to essentially gain full access to your computer including “sensitive information, confidential information, intellectual property, customer data, financial data – the list goes on – including the ability to make changes,” Kyle Kennedy, … Continue reading Stock in News: Apple (NASDAQ AAPL) & the Bash Bug

Richard Atkins